Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
Schneider Electric SE
PAR:SU
|
FR |
|
N
|
Nomura Holdings Inc
F:NSE
|
JP |
|
L
|
Linus Digital Finance AG
F:LDF
|
DE |
|
Danone SA
PAR:BN
|
FR |
|
IGM Biosciences Inc
NASDAQ:IGMS
|
US |
|
Thomson Reuters Corp
TSX:TRI
|
CA |
|
F
|
F5 Inc
XMUN:FFV
|
US |
|
Bigtincan Holdings Ltd
ASX:BTH
|
AU |
|
Indofood Sukses Makmur Tbk PT
IDX:INDF
|
ID |
|
A
|
AAPICO Hitech PCL
SET:AH
|
TH |
|
S
|
SAPPE PCL
SET:SAPPE
|
TH |
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
R
|
Renault SA
OTC:RNSDF
|
FR |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
Dividends
Dividend Yield
Shanghai Pharmaceuticals Holding Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd have decreased by 0%.
Payout Ratio
Shanghai Pharmaceuticals Holding Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Shanghai Pharmaceuticals Holding Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Shanghai Pharmaceuticals Holding Co Ltd
| Average Annual Return | 1.89% |
| Standard Deviation of Annual Returns | 14.18% |
| Max Drawdown | -40% |
| Market Capitalization | 63.6B CNY |
| Shares Outstanding | 3 708 360 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Shanghai Pharmaceuticals Holding Co Ltd's latest stock split occurred on Aug 16, 2007
The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.
The adjusted shares began trading on Aug 16, 2007. This was stock split number 7 in Shanghai Pharmaceuticals Holding Co Ltd's history, following the previous one in Jun 19, 2003.
